阿尔兹海默病的APOE基因及神经影像标志物:系统回顾和荟萃分析
Objective: We aimed to examine the association of apolipoprotein E (APOE) ε4 genotype with neuroimaging markers of Alzheimer's disease: hippocampal volume, brain amyloid deposition and cerebral metabolism. Methods: We performed a systematic review and metaanalysis of 14 cross-sectional studies identified in Pubmed from 1996 to 2014 (n=1628). The pooled standard mean difference (SMD) was used to estimate the association between APOE and hippocampal volume and amyloid deposition. Meta-analysis was performed using effect size signed differential mapping using coordinates extracted from clusters with statistically significant difference in cerebral metabolic rate for glucose between APOE ε4+ and ε4- groups. Results: APOE ε4 carrier status was associated with atrophic hippocampal volume (pooled SMD: -0.47; 95% CI -0.82 to -0.13; p=0.007) and increased cerebral amyloid positron emission tomography tracer ( pooled SMD: 0.62, 95% CI 0.27 to 0.98, p=0.0006). APOE ε4 was also associated with decreased cerebral metabolism, especially in right middle frontal gyrus. Conclusions: APOE ε4 was associated with atrophic hippocampal volume in MRI markers, increased cerebral amyloid deposition and cerebral hypometabolism. Theses associations may indicate the potential role of the APOE gene in the pathophysiology of Alzheimer's disease. © 2015, BMJ Publishing Group. All rights reserved.
上一篇: 终末期肾病患者接受非手术牙周治疗的临床效果和全身效果:一项为期6个月的临床随机对照试验
下一篇: 胆碱酯酶抑制剂和美金刚胺治疗帕金森病认知损害、帕金森病痴呆和路易氏体型痴呆的效果和安全性:系统回顾的荟萃分析和试序列分析
来源: Scopus
- 您可能感兴趣的文章
-